Inventor · disambiguated record
Hidechika Okada
Also filed as: OKADA HIDECHIKA
7 granted patents·3 pending applications·16 citations·filing 1989–2014
78Inventor score
Files withOKADA HIDECHIKA5HIDECHIKA OKADA1INST NAGOYA IND SCIENCE RES1INST PROTEIN SCIENCE CO LTD1OTSUKA PHARMA CO LTD1
Top patents by PatentIndex Score
10 records- 0180US7763708B2Methods and compositions for modulating C5-a-mediated inflammatory responsesINST PROTEIN SCIENCE CO LTD·Filed 2005·Granted Jul 27, 2010·7 cites·15 claims
- 0270US7914790B2Human IgM antibody lysing activated lymphocytes under mediation by homologous complementOKADA HIDECHIKA·Filed 2003·Granted Mar 29, 2011·2 cites·3 claims
- 0356US7595050B2Human IGM monoclonal antibody capable of inducing apoptosis in HIV-infected cellsINST NAGOYA IND SCIENCE RES·Filed 2003·Granted Sep 29, 2009·0 cites·3 claims
- 0447US2016068571A1Therapeutic agent for cardiac tamponadeRES INST FOR PROTEIN SCIENCE CO·Filed 2014·Application pending·0 cites
- 0544US7144864B2Carboxypeptidase R inhibiting peptideHIDECHIKA OKADA·Filed 2002·Granted Dec 5, 2006·0 cites·4 claims
- 0641US2006275826A1Artificial antibody comprising complementary peptideOKADA HIDECHIKA·Filed 2006·Application pending·0 cites
- 0736US2005226886A1Preferential detection of procarboxypeptidase R (thrombin activatable fibrinolyisis inhibitor) by enzyme-linked immunosorbent assayOKADA HIDECHIKA·Filed 2005·Application pending·0 cites
- 0834US5521296AGlycoprotein and gene coding thereforOKADA HIDECHIKA·Filed 1991·Granted May 28, 1996·3 cites·1 claims
- 0932US5179198AGlycoprotein and gene coding thereforOKADA HIDECHIKA·Filed 1989·Granted Jan 12, 1993·4 cites·1 claims
- 1028US6190863B1Sugar chain-recognizing antibodies and remedies for HIV infectious diseasesOTSUKA PHARMA CO LTD·Filed 1996·Granted Feb 20, 2001·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Hidechika Okada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →